HomeAI · summaries
Storia in 13 fonti
Alibaba to pay US $600M to settle allegations it allowed illegal sales
Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
apnews.com
Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government. The company faced allegations of selling and importing illegal pharmaceuticals and equipment…
- ·
channelnewsasia.com
Alibaba, AUS Merchant Services to pay $600 million to resolve alleged illegal pharmaceuticals sales, DOJ says
WASHINGTON, July 1 : The U.S. Justice Department said on Wednesday that Alibaba and AUS Merchant Services have agreed to pay $600 million to resolve allegations that they failed…
- ·
Alibaba to pay $600 million to resolve US drug sales probe
WASHINGTON, July 1 : Chinese technology and e-commerce giant Alibaba and its U.S.-based payment processor have agreed to pay $600 million to resolve allegations that they failed…
- ·
cryptobriefing.com
Alibaba agrees to pay $600M to settle federal probe into drug sales
Alibaba and its US payment processor will pay $600 million to settle a federal investigation into illegal drug sales facilitated on the company's platforms.
- ·
thenextweb.com
Alibaba and its US payment processor will pay 600 million dollars to settle a DOJ probe into illegal drug sales
Alibaba admitted its platform failed to prevent 80,000 illegal pharmaceutical purchases worth over 200 million dollars between 2016 and 2024.
- ·
abcnews.com
Alibaba to pay US $600M to settle allegations it allowed illegal sales
Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government
- ·
arabnews.com
Alibaba to pay US $600m to settle allegations it allowed illegal drug and equipment sales
WASHINGTON: The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the US government over allegations that the Hangzhou-based firm sold and imported…
- ·
morningstar.com
Correction to Alibaba, U.S. Payment Processor in DOJ Settlement Article
AUS Merchant Services is a subsidiary of Ant Group. "Alibaba, U.S. Payment Processor to Pay $600M in DOJ Settlement Over Illegal Drug Sales," at 3:42 p.m. ET, incorrectly said AUS…
- ·
valor.globo.com
Alibaba chega a acordo para encerrar processo nos EUA sobre comércio de itens proibidos
Segundo a Justiça americana, a Alibaba admitiu que falhou, entre 2016 e 2024, em impedir cerca de 80 mil vendas de produtos químicos, drogas e equipamentos de falsificação…
- ·
Alibaba to pay $600M to resolve US drug sales probe
Alibaba will pay $600 million to settle a DOJ investigation into illegal pharmaceutical sales on Alibaba.com and AliExpress.com spanning 2016 to 2024.
- ·
scmp.com
Alibaba to pay US$600 million to settle US probe into illegal product sales
Amount resolves dispute with US government over allegations firm sold and imported illegal pharmaceuticals and controlled substances into US.
- ·
thehindubusinessline.com
Alibaba, its payment processor to pay $600 million to resolve US drug sales probe
The companies entered into non-prosecution agreements to resolve allegations that they violated the US Federal Food, Drug, and Cosmetic Act by failing to prevent merchants from…
- ·
ansa.it
Alibaba patteggia con gli Usa, 600 milioni per chiudere indagine su vendite illegali - Notizie - Ansa.it
Alibaba e il suo processore di pagamenti statunitense Aus Merchant Services pagheranno complessivamente 600 milioni di dollari per chiudere un'indagine del Dipartimento di…
- ·
wiwo.de
Technologiekonzern: Alibaba legt US-Rechtsstreit bei
US-Behörden werfen dem chinesischen Unternehmen den Verkauf illegaler Produkte vor. Der Rechtsstreit soll nun mit einer Zahlung in Höhe von 600 Millionen US-Dollar beigelegt…
- ·
soldionline.it
Alibaba paga 600 milioni negli Usa: cosa c’è dietro all’accordo - SoldiOnline.it
Alibaba e Aus Merchant Services pagano 600 milioni di dollari per chiudere l’indagine USA su vendite illegali e attrezzature per farmaci contraffatti.